Mads Krogsgaard Thomsen, CEO of Novo Nordisk Foundation, discusses European competitiveness.

Trump added Denmark to his growing list of tariff targets — including Canada, Mexico and China — as he has increasingly ...

(Reuters) - European shares were subdued on Tuesday, as rising financials and healthcare shares countered broader losses ...

Mexico and China — as he has increasingly spoken of the U.S. taking Greenland off Denmark’s hands. Danish multinational pharmaceutical giant Novo Nordisk is the sole owner of semaglutide ...

Eli Lilly (LLY 1.45%) began a roll in late 2020 that lasted almost four years. During that time, it became the world's ...

US stocks closed lower afer the S&P 500 touched an intraday record high early in the day. As tariff worries eased, mixed ...

It's a big week ahead as the U.S. Federal Reserve, European Central Bank and Bank of Canada hold their first meetings of 2025 ...

Novo Nordisk is increasing its U.S. production to ... the company serves much of the U.S. market from a factory in Mexico, as well as a new carbon-neutral facility in Virginia.

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

Denmark is the leading supplier of hearing aids to the U.S., per The Times, and is home to Novo Nordisk, the maker of ... wants 25% tariffs on imports from Mexico and Canada and an additional ...